Financial Investments

Patricia Industries’ financial investments consist of European, Asian and North American investments that are a part of an Investor Growth Capital legacy portfolio. Some of these investments are listed, while the majority are unlisted.

The majority of these holdings are in the U.S. and we typically hold minority shares with a variety of shareholder rights attached. While some of these holdings could be attractive, our ambition is to exit most of them in a way that creates value, and then reinvest in subsidiaries.

Our Asian portfolio is limited including our largest holding NS Focus, with an ambition to fully divest in 2018. 

Our European portfolio is a mix of listed and unlisted holdings. We are currently evaluating whether or not some of these assets are a good fit to our long term ambition.

Financial investments 

Acquia

U.S.

Technology

Affibody

Nordics

Healthcare

Agile Therapeutics

U.S.

Healthcare

AgJunction

U.S.

Technology

Alligator Bioscience

Nordics

Healthcare

Atlas Antibodies

Nordics

Healthcare

Better Finance

U.S.

Technology

CallFire

U.S.

Technology

CDP Group

Asia

Technology

Chelsio

U.S.

Technology

ChinaCache

Asia

Technology

Conductor

U.S.

Technology

Corcept

U.S.

Healthcare

eSilicon

U.S.

Technology

ExaGrid

U.S.

Technology

Guavus

U.S.

Technology

HireVue

U.S.

Technology

Innovative Micro Technology

U.S.

Technology

Intuity Medical

U.S.

Healthcare

Mattersight

U.S.

Technology

Memira

Nordics

Healthcare

Neuronetics

U.S.

Healthcare

Newron Pharmaceuticals

Nordics

Healthcare

NS Focus

Asia

Technology

PulsePoint

U.S.

Technology

Retail Solutions

U.S.

Technology

RocketLawyer

U.S.

Technology

Spigit

U.S.

Technology

Talix

U.S.

Technology

TearScience

U.S.

Healthcare

Tobii

Nordics

Technology

Trilliant

U.S.

Technology

United Information Technology

Asia

Technology

WhiteHat

U.S.

Technology

Back